Keywords: Watson Pharma, First-quarter 2011 financial results
Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million
Article | 28 April 2011
USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of $876.5 million for the first quarter ended March 31, 2011, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
